Home Cart Sign in  
Chemical Structure| 533-30-2 Chemical Structure| 533-30-2
Chemical Structure| 533-30-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Walczak, Juliusz Maksymilian ; Iwaszkiewicz-Grzes, Dorota ; Ziomkowska, Michalina ; Sliwka-Kaszynska, Magdalena ; Dasko, Mateusz ; Trzonkowski, Piotr , et al.

Abstract: The group of 18 new amide derivatives of mycophenolic acid (MPA) and selected heterocyclic amines was synthesised as potential immunosuppressive agents functioning as inosine-5′-monophosphate dehydrogenase (IMPDH) uncompetitive inhibitors. The synthesis of 14 of them employed uronium-type activating system (TBTU/HOBt/DIPEA) while 4 of them concerned phosphonic acid anhydride method (T3P/Py) facilitating amides to be obtained in moderate to excellent yields without the need of phenolic group protection. Most of optimised protocols did not require complicated reaction work-ups, including chromatographic, solvent-consuming methods. The biological activity assay was performed on the T-Jurkat cell line and peripheral mononuclear blood cells (PBMCs) which are both dedicated for antiproliferative activity determination. Each of designed derivatives was characterised by reduced cytotoxicity and benzoxazole analogue (A2) revealed the most promising activity. Subsequently, an observed structure-activity relationship was discussed.

Keywords: Mycophenolic acid ; amide derivatives ; heterocycles ; benzoxazole ; IMPDH inhibition

Alternative Products

Product Details of 6-Amino-1,3-benzothiazole

CAS No. :533-30-2
Formula : C7H6N2S
M.W : 150.20
SMILES Code : C1=CC(=CC2=C1N=CS2)N
MDL No. :MFCD00015461
InChI Key :FAYAYUOZWYJNBD-UHFFFAOYSA-N
Pubchem ID :68288

Safety of 6-Amino-1,3-benzothiazole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of 6-Amino-1,3-benzothiazole

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 533-30-2 ]

[ 533-30-2 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 533-30-2 ]
  • [ 381-98-6 ]
  • [ 1260010-12-5 ]
YieldReaction ConditionsOperation in experiment
19.67% With hydroquinone; In toluene; Example 170Preparation of 1-benzothiazol-6-yl-3-pyridin-3-yl-4-trifluoromethyl-imidazolidin-2-one (170A) Step-1: Synthesis of Intermediate 2-(Benzothiazol-6-ylaminomethyl)-3,3,3-trifluoro-propionic Acid (I-170a) Benzothiazol-6-ylamine (1 g, 6.66 mmol) was reacted with 2-trifluoromethyl-acrylic acid (1.39 g, 9.99 mmol), benzene-1,4-diol (51.3 mg, 0.46 mmol) and toluene (10 mL) to afford the crude product. Purification by column chromatography on silica gel (30% ethyl acetate in hexane) afforded 380 mg of the product (19.67% yield).1H NMR (300 MHz, DMSO-d6): delta 13.8-13.0 (bs, 1H), 8.95 (s, 1H), 7.8 (d, 1H), 7.2 (d, 1H), 6.95-6.85 (dd, 1H), 3.75-3.50 (m, 3H)LCMS: 100%, m/z=291.1 (M+1)
19.67% With hydroquinone; In toluene; Ben/othia/ol-6-ylamine ( Ig. 6.6<>mmol) was reacted with ^-trifluoromcth) l- acrylic acid ( 1.39g. y.99mmol). bouene- 1 ,4-diol (51.3mg.0 46mmoi) and toluene( 10ml-) to afford the crude product. Purification In column ehromatographs on silica gel (30% ethyl acetate in he.anc) afforded 380tng of the pr
  • 2
  • [ 2631-77-8 ]
  • [ 533-30-2 ]
  • 2-((benzo[d]thiazol-6-ylimino)methyl)-4,6-diiodophenol [ No CAS ]
YieldReaction ConditionsOperation in experiment
81% In methanol; at 40 - 50℃; General procedure: L1H/L2H/L3H were synthesized by adding 3-nitro-salicylaldehyde/3,5-diiodo-salicylaldehyde/3-methoxy-5-bromo-salicylaldehyde (10 mM) into a stirred methanolic solution of 6-amino-benzothiazole (10 mM) in 1:1 M ratio (Scheme 1). The reaction mixture wasrefluxed on an oil bath for 3-4 h by maintaining temperature at 40-50 C and the progressof the reaction was monitored by TLC. The resulting solid product was isolatedand washed with petroleum ether and methanol. The Schiff bases were dried in a desiccatorover anhydrous CaCl2.
 

Historical Records

Technical Information

Categories